276890-57-4Relevant articles and documents
Synthesis of [3H]-labelled 4-[ethyl[2,5,6-trimethyl-7-(2,4,6- trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2,3-[3H]-butan-1- ol: A high affinity radioligand for the corticotropin-releasing hormone type 1 receptor
Hiebel, Anne-Cecile,Partilla, John S.,Rothman, Richard B.,Jacobson, Arthur E.,Rice, Kenner C.
, p. 635 - 640 (2006)
[3H]-Labelled 4-[ethyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl) pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2,3-[3H]-butan-1-ol (3b) was prepared as a novel non-peptidic radiolabelled high affinity antagonist of the corticotropin-releasing
Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor
Hsin, Ling-Wei,Webster, Elizabeth L.,Chrousos, George P.,Gold, Philip W.,Eckelman, William C.,Contoreggi, Carlo,Rice, Kenner C.
, p. 707 - 710 (2000)
A series of fluoro-substituted 4-(diakylamino)pyrrolo[2,3-d]pyrimidines was synthesized and their binding affinity for corticotropin-releasing hormone type 1 receptor (CRHR1) was investigated. Compounds 11a and 11b possessed very high CRHR1 affinity (K(i) = 3.5, 0.91 nM, respectively). They are promising candidates for the development of 18F-containing nonpeptide PET radioligands for CRHR1. Published by Elsevier Science Ltd.